Marché des dispositifs de débridement des plaies en Asie-Pacifique – Tendances et prévisions du secteur jusqu’en 2028

Analyse et perspectives du marché : Marché des dispositifs de débridement des plaies en Asie-Pacifique

Le marché des dispositifs de débridement  des plaies en Asie-Pacifique devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 5,50 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 130,70 millions USD d'ici 2028 contre 86,52 millions USD en 2020. L'incidence croissante du diabète et la croissance des nouvelles avancées technologiques pour les dispositifs de débridement des plaies sont susceptibles d'être les principaux moteurs qui propulsent la demande du marché au cours de la période de prévision.

L'élimination des tissus morts et nécrotiques pour accélérer le processus de cicatrisation des plaies est réalisée à l'aide de dispositifs de débridement. Les dispositifs de débridement comprennent des dispositifs à ultrasons, une thérapie larvaire et des dispositifs à tampons mécaniques. La procédure de débridement des plaies peut être réalisée de différentes manières, telles que la méthode autolytique, la méthode enzymatique, la chirurgie et autres. La demande de dispositifs de débridement des plaies augmente car ces dispositifs éliminent les tissus morts et nécrotiques et améliorent la circulation sanguine de la zone affectée, réduisant ainsi les risques d'infection bactérienne.

Les méthodes autolytiques sont généralement utilisées pour la procédure de débridement car elles utilisent le processus de guérison du corps pour éliminer les cellules mortes et nécrotiques.

La présence d'un grand nombre d'acteurs du marché, impliqués dans l'offre de produits et services de dispositifs de débridement des plaies, ouvre la voie à la croissance du marché des dispositifs de débridement des plaies. De plus, le potentiel de croissance des dispositifs de débridement des plaies dans les économies émergentes renforce la croissance du marché des dispositifs de débridement des plaies. Le coût accru des produits de débridement des plaies, les incohérences dans le matériau utilisé et les lois réglementaires imposées sont les contraintes qui peuvent entraver la croissance du marché.

The Asia-Pacific wound debridement devices market report provides details of market share, new developments, and impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Wound Debridement Devices Market Scope and Market Size

Asia-Pacific wound debridement devices market is segmented on the basis of product, method, wound type and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of product, the Asia-Pacific wound debridement devices market is segmented into hydrosurgical, low-frequency ultrasound, mechanical, larval therapy and others. In 2021, hydrosurgical segment is expected to dominate the wound debridement devices market due to growing cases of diabetic and pressure ulcers, increase in geriatric population and upcoming wound diagnostic centres.
• On the basis of method, the Asia-Pacific wound debridement devices market is segmented into autolytic, enzymatic, surgical, mechanical and maggot. In 2021, autolytic segment is expected to dominate the wound debridement devices market owing to the increasing cases of chronic wounds and preferred method by the patients.
• On the basis of wound type, the Asia-Pacific wound debridement devices market is segmented into surgical wounds, diabetic ulcers, burns, pressure ulcers, venous ulcers and others. In 2021, surgical wounds segment is expected to dominate the wound debridement devices market due to rise of accidents and  growth in number of surgeries.
• On the basis of end user, the Asia-Pacific wound debridement devices market is segmented into hospitals, wound care centers, ambulatory centers, home healthcare, clinics and community healthcare. In 2021, hospitals segment is expected to dominate the wound debridement devices market due to the rising number of hospitals across the globe and availability of wound debridement devices in the hospitals.

Asia-Pacific Wound Debridement Devices Market Country Level Analysis

Asia-Pacific wound debridement devices market is analysed and market size information is provided by products, wound type, method, and end user.

The countries covered in the wound debridement devices market report are the Japan, China, India, South Korea, Australia, Singapore, Indonesia, Philippines, and rest of Asia-Pacific.

Asia-Pacific is expected to grow with the highest CAGR in the forecasted periods as in the Asia-Pacific’s Countries demand for wound debridement devices product is increasing very rapidly with the urbanization and laboratory automation. China is expected to dominate in the market in the Asia-Pacific market. China is one of the leading countries to inculcate wound debridement devices market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

The Growth Potential for Wound Debridement Devices in Emerging Economies and the Strategic Initiatives by Market Players are creating new Opportunities in the Asia-Pacific Wound Debridement Devices Market 

 Asia-Pacific Wound Debridement Devices Market also provides you with detailed market analysis for every country growth in particular industry with wound debridement devices sales, impact of advancement in the wound debridement devices and changes in regulatory scenarios with their support for the wound debridement devices market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Asia Pacific Wound Debridement Devices Market Share Analysis

 Asia-Pacific wound debridement devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to wound debridement devices market.

The major companies providing the Asia-Pacific wound debridement devices are Smith+Nephew, Integra LifeSciences Corporation, Zimmer Biomet, Mölnlycke Health Care AB, Medtronic, B. Braun Melsungen AG, Coloplast Group, Hollister Incorporated, Olympus Corporation, Advanced Medical Solutions Group plc, BSN Medical, Lohmann and Rauscher GmbH, Misonix, Söring GmbH among others.

DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The strategic initiatives by market players along with new technological advancements for wound debridement devices are bridging the gap for chronic wounds treatment. 

For instance,

• En janvier 2017, Integra Life Sciences Corporation a acquis DERMA SCIENCES. Grâce à cette acquisition, Integra Life Sciences a accéléré sa stratégie de soins avancés des plaies en ajoutant les produits à base de tissu amniotique de Derma Sciences à son portefeuille de produits

La collaboration, les coentreprises et d’autres stratégies des acteurs du marché améliorent le marché de l’entreprise sur le marché des dispositifs de débridement des plaies, ce qui offre également l’avantage à l’organisation d’améliorer son offre pour le marché des dispositifs de débridement des plaies.

SKU-23884